Login
$PCRX
$36.38 -$0.04 (0.11%) Close

$PCRX 4/A SEC Filings

Filed On Filing
19 Mar 2026 Form 4/A: Kronenfeld Mark A., Director

Received 6,163 shares as a grant or award

13 Aug 2024 Form 4/A: Bigal Marcelo, Director

Bought 3,400 shares ($40.8K)

15 Apr 2013 Form 4/A: Sanderling Venture Partners Vi Lp, 10% owner and 4 others

Received 79,031 shares by exercise ($662K) · Sold 25,560 shares ($663K) · Sold 348,951 shares ($9.72M)

15 Apr 2013 Form 4/A: Sanderling Venture Partners Vi Lp, 10% owner and 5 others

Disposed of 98,596 shares (Other Transaction) · Sold 500,000 shares ($9.47M)

11 Jun 2012 Form 4/A: Patou Gary, Chief Medical Officer

Granted 40,000 Stock Option (Right to Buy)

17 Feb 2011 Form 4/A: Mpm BioVentures Iv Qp Lp, 10% owner and 9 others

Received 2,200,247 shares by conversion · Bought 535,714 shares ($3.75M)

17 Feb 2011 Form 4/A: Evnin Luke, Director

Received 2,200,247 shares by conversion · Bought 535,714 shares ($3.75M)

17 Feb 2011 Form 4/A: Kailian Vaughn M, 10% owner and 1 other

Received 2,200,247 shares by conversion · Bought 535,714 shares ($3.75M)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support